Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Remifentanil

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

  • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).


    The EU Clinical Trials Register currently displays   43881   clinical trials with a EudraCT protocol, of which   7295   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    145 result(s) found for: Remifentanil. Displaying page 1 of 8.
    1  2  3  4  5  6  7  8  Next»
    EudraCT Number: 2015-000051-24 Sponsor Protocol Number: RemiPedEntropy_v1.0 Start Date*: 2015-03-26
    Sponsor Name:Klaus Olkkola/University of Helsinki
    Full Title: The pharmacokinetics and –genomics of remifentanil, and its effects on the depth-of-anaesthesia monitors and the protein synthesis in children.
    Medical condition: otherwise healthy patients undergoing an operation necessitating general anaesthesia
    Disease:
    Population Age: Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: FI (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2019-000961-19 Sponsor Protocol Number: 2019/376 Start Date*: 2019-08-26
    Sponsor Name:Helse Fonna
    Full Title: “Haemodynamic stability during induction of general anesthesia with propofol and remifentanil: A randomized, controlled, double-blind study comparing medium and low remifentanil doses.”
    Medical condition: In daily clinical work we observe a hypotensive effect and a reduction in heart rate when induction of general anesthesia is performed using propofol and remifentanil. It is difficult to differenti...
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: NO (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2014-004346-10 Sponsor Protocol Number: N/A Start Date*: 2015-04-15
    Sponsor Name:Alder Hey Children's NHS Foundation Trust
    Full Title: Study to evaluate the optimal dose of remifentanil infusion(effective dose in 80% of patients) required to ensure apnoea (of 30 seconds duration) during magnetic resonance imaging of the heart unde...
    Medical condition: Study refers to the use of this medicine during anaesthesia given during the investigation of congenital heart disease.
    Disease:
    Population Age: Infants and toddlers, Children, Under 18 Gender: Male, Female
    Trial protocol: GB (GB - no longer in EU/EEA)
    Trial results: (No results available)
    EudraCT Number: 2008-000597-21 Sponsor Protocol Number: REMISYD Start Date*: 2008-05-27
    Sponsor Name:Kuopio University Hospital, Anesthesiology Clinic
    Full Title: Requirement of analgesics after two remifentanil dosing regimen in cardiac surgery.
    Medical condition: Post-operative requirement of analgesics in relation to remifentanil dose administered during cardiac surgery is to be investigated.
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FI (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2010-018233-21 Sponsor Protocol Number: WEC 0910 Start Date*: 2010-03-31
    Sponsor Name:Leiden University Medical Centre
    Full Title: Modeling the respiratory effects of subanesthetic doses of propofol under closed-loop or non-steady-state conditions without and with a remifentanil background infusion in healthy volunteers.
    Medical condition: This study is performed in healthy volunteers. The study is aimed at investigating the effect of propofol and remifentanil-propofol interaction on breathing in awake, non-artificially ventilated vo...
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2010-020042-94 Sponsor Protocol Number: LS07-040 Start Date*: 2010-09-02
    Sponsor Name:Medizinische Universität Wien, Universitätsklinik für Anästhesie, Allgemeine Intensivmedizin
    Full Title: The Effect of High-dose Remifentanil on the Reversal of Neuropathic Pain in Postherpetic Patients
    Medical condition: Post herpetic hyperalgesia
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: AT (Completed)
    Trial results: View results
    EudraCT Number: 2012-002533-10 Sponsor Protocol Number: SuRe-001 Start Date*: 2013-05-22
    Sponsor Name:UMCG
    Full Title: Comparison of the effects of atropine on haemodynamics and tissue oxygenation in anaesthesia with propofol and sufentanil versus propofol and remifentanil’
    Medical condition: Comparison of the effects of atropine on haemodynamics and tissue oxygenation in anaesthesia with propofol and sufentanil versus propofol and remifentanil
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2019-000958-56 Sponsor Protocol Number: 2019/375 Start Date*: 2019-08-16
    Sponsor Name:Helse Fonna
    Full Title: “Haemodynamic stability during induction of general anesthesia with propofol and remifentanil: A randomized, controlled, double-blind study comparing low vs high propofol doses.”
    Medical condition: In daily clinical work we observe a hypotensive effect and a reduction in HR when induction of general anesthesia is performed using propofol and remifentanil. It is difficult to differentiate the ...
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: NO (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2008-007972-70 Sponsor Protocol Number: 11/2008 FDB Start Date*: 2009-01-22
    Sponsor Name:University Hospital Leuven
    Full Title: Transplacentar pharmacokinetics of remifentanil
    Medical condition: Transplacentar pharmacokinetics of Remifentanil
    Disease:
    Population Age: In utero, Under 18 Gender: Female
    Trial protocol: BE (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2005-004479-38 Sponsor Protocol Number: REG 31/05 Start Date*: 2006-01-12
    Sponsor Name:AZIENDA OSPEDALIERA "OSPEDALI RIUNITI DI BERGAMO" (A.O. DI RILIEVO NAZIONALE)
    Full Title: Effects of the association remifentanil-propofol in TCI on the respiratory exchanges: comparison between controlled and spontaneous ventilation
    Medical condition: general anesthesia
    Disease:
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: IT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2019-004121-25 Sponsor Protocol Number: NMBA_ELDERLY2019ROCU_REMI Start Date*: 2019-12-17
    Sponsor Name:Rigshospitalet
    Full Title: A single-blinded multicenter randomized study comparing intubating conditions after either rocuronium 0.6 mg/kg or remifentanil 2 µg/kg in elderly patients.
    Medical condition: The aim of this study is to determine the effect on intubating conditions and laryngeal morbidity after either rocuronium 0.6 mg/kg or remifentanil 2 µg/kg in patients with age ≥ 80 years.
    Disease: Version SOC Term Classification Code Term Level
    21.1 100000004865 10002323 Anesthesia general LLT
    Population Age: Elderly Gender: Male, Female
    Trial protocol: DK (Completed)
    Trial results: View results
    EudraCT Number: 2007-003151-36 Sponsor Protocol Number: AGO/2007/006 Start Date*: 2007-08-01
    Sponsor Name:University Hospital Ghent
    Full Title: Sevoflurane-Remifentanil interaction: Multiple response surfaces, validation of calibration stimuli, validation of the intraoperative isobole concept and investigating remifentanil induced opioid t...
    Medical condition: American Society of Anesthesia class I and II patients scheduled for surgery under general anesthesia
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: BE (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2008-007322-19 Sponsor Protocol Number: RPC190 Start Date*: 2009-07-07
    Sponsor Name:Queen Victoria Hospital NHS Foundation Trust
    Full Title: A Comparison of Remifentanil Patient-Controlled Analgesia vs. Oral Morphine Analgesia for Dressing Changes in Burns Patients.
    Medical condition: Pain experienced by patients with pre-existing burns presenting to the burns outpatients unit requiring two or more dressing changes
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: (No results available)
    EudraCT Number: 2019-001677-81 Sponsor Protocol Number: PTRS01 Start Date*: 2019-11-27
    Sponsor Name:Akershus Universitetssykehus
    Full Title: Remifentanil tapering and post-adenotonsillectomy pain in children: a randomised, placebo controlled, double blind study
    Medical condition: Tonsillectomy and adenotonsillectomy
    Disease:
    Population Age: Infants and toddlers, Children, Under 18 Gender: Male, Female
    Trial protocol: NO (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2014-000962-23 Sponsor Protocol Number: REDEX Start Date*: 2014-07-10
    Sponsor Name:Consorci Parc de Salut Mar
    Full Title: Effect of dexmedetomidine on monitoring of motor evoked potentials in patients undergoing supratentorial craniotomy or brainstem surgery
    Medical condition: Patients scheduled for supratentorial craniotomy or brainstem surgery with intraoperative monitoring of motor evoked potentials (MEP).
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2012-005257-22 Sponsor Protocol Number: RG_12-151 Start Date*: 2013-07-12
    Sponsor Name:University of Birmingham
    Full Title: Remifentanil intravenous patient controlled analgesia (PCA) versus intramuscular pethidine for pain relief in labour: a randomised controlled trial
    Medical condition: Childbirth
    Disease:
    Population Age: Gender: Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2013-003220-36 Sponsor Protocol Number: 45112 Start Date*: 2014-05-21
    Sponsor Name:Albert Schweitzer hospital
    Full Title: Remifentanil use for procedural sedation and analgesia in the emergency department
    Medical condition: The research will be conducted in patients that need short painfull treatment in the emergency department and with an indication for PSA. These treatments include: repositioning of fractures, repos...
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: NL (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2013-002883-20 Sponsor Protocol Number: WALIBI-001 Start Date*: 2013-09-30
    Sponsor Name:University Medical Center Groningen
    Full Title: Walking the Isobole of drug Interaction: Comparison of hemodynamic effects, cerebral and tissue oxygenation for 4 equipotent combinations of propofol and remifentanil
    Medical condition: elective ophthalmic surgery under general anesthesia.
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2005-000877-23 Sponsor Protocol Number: JM/JS/4551 Start Date*: 2005-04-11
    Sponsor Name:Oxford Radcliffe Hospitals NHS trust
    Full Title: Is Remifentanil better than Propofol in providing optimal conditions for an awake fibreoptic intubation?
    Medical condition: Awake fibre optic intubation is an anaesthetic technique used to intubate patients with a difficult to manage airway. It s a procedure by which a tracheal tube is inserted in a patients trachea wh...
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2007-000736-10 Sponsor Protocol Number: Start Date*: 2007-11-05
    Sponsor Name:
    Full Title: A comparison of pethidine/meperidine intramusculary and remifentanil patient-controlled analgesia during labor in Westfriesgasthuis
    Medical condition: Women in labour
    Disease: Version SOC Term Classification Code Term Level
    9.1 10036585 Pregnancy, puerperium and perinatal conditions SOC
    Population Age: Adults Gender: Female
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    1  2  3  4  5  6  7  8  Next»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Mon May 20 07:28:30 CEST 2024 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA